コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 deregulated nutrient sensing and defects in proteostasis).
2 etal muscle protein synthesis and breakdown (proteostasis).
3 al roles in maintaining protein homeostasis (proteostasis).
4 key role in maintaining protein homeostasis (proteostasis).
5 jectories are significantly impacted by host proteostasis.
6 degradation of misfolded proteins to restore proteostasis.
7 Protein chaperones play a critical role in proteostasis.
8 is a key regulator of podocyte foot process proteostasis.
9 g neuroprotective effects involving improved proteostasis.
10 NA, indicative of a profound perturbation to proteostasis.
11 f sequence-specific signals in mitochondrial proteostasis.
12 rone and degradation pathways promoting mHtt proteostasis.
13 nship between the TRC40 pathway and cellular proteostasis.
14 various signaling pathways or during general proteostasis.
15 ibutions of IR and IGF1R signaling to muscle proteostasis.
16 ivo to survive multiple stressors related to proteostasis.
17 creased protein aggregation and altered cell proteostasis.
18 to impaired proteasome function and altered proteostasis.
19 to the cytosol and is essential to maintain proteostasis.
20 hat may have specialized roles in regulating proteostasis.
21 a posttranslational modification to maintain proteostasis.
22 and ubiquitination to ciliary signalling and proteostasis.
23 associated with stress or general decline in proteostasis.
24 proper neddylation levels for CRL-dependent proteostasis.
25 insight into disease mechanisms and cellular proteostasis.
26 ess the potential of the chemical biology of proteostasis.
27 e their contribution to maintaining cellular proteostasis.
28 aintain genome stability by assuring nuclear proteostasis.
29 which UPR activation regulates extracellular proteostasis.
30 ins by the proteasome system is critical for proteostasis.
31 l protein synthesis is paramount to maintain proteostasis.
32 hich permits simultaneous stress sensing and proteostasis.
33 y reduce ER protein folding load and restore proteostasis.
34 s to PERK regulation of pancreatic beta-cell proteostasis.
35 defective mitochondrial import and impaired proteostasis.
36 recently been associated with alterations in proteostasis.
37 nvolved in coordinating ER and extracellular proteostasis.
38 ROS) leads to perturbations in mitochondrial proteostasis.
39 ular processes, including the maintenance of proteostasis.
40 cal processes that are critical for cellular proteostasis.
41 ochondria in metabolism, ROS regulation, and proteostasis.
42 ay be physiologically relevant in ER luminal proteostasis.
43 chaperones with important roles in cellular proteostasis.
46 new insights into the physiology of cellular proteostasis and a rational basis for developing effecti
48 orylation regulates not only cell-autonomous proteostasis and amino acid metabolism, but also affects
49 ulates the ER stress response and elicits ER proteostasis and autophagy machinery homeostasis in huma
53 d lysosomal protein degradation for cellular proteostasis and clearance of aggregated proteins, these
54 0 has an unexpected negative effect on Abeta proteostasis and cognition in APP mouse models demonstra
57 ffect also included an increase in lysosomal proteostasis and enhanced clearance of lysosomal storage
60 udy reveals a novel mechanism regulating VHL proteostasis and function, which is significant for iden
63 s underlying the regulation of mitochondrial proteostasis and how those mechanisms change with age is
64 tent and specific correction of F508del-CFTR proteostasis and in synergy with pharmacochaperones.
66 conceptually new role for H2O2 signaling in proteostasis and lifespan control and shed new light on
67 a model in which VAP-ligand binding couples proteostasis and lipid homeostasis leading to observed p
68 F signaling has profound effects on neuronal proteostasis and maintenance of cell morphology in vivo.
69 es have broad implications for CRL-dependent proteostasis and mechanisms of E3-mediated UB ligation.
70 tracycline derivative-disturbs mitochondrial proteostasis and metabolic activity, and induces widespr
72 ut formerly unrecognized, branch of neuronal proteostasis and mitochondrial quality control, which, w
77 mechanism that helps maintain intracellular proteostasis and promote cell survival during ER stress
84 s eliminate defective polypeptides to ensure proteostasis and to avoid the toxicity of protein aggreg
86 tabolizes intracellular contents to maintain proteostasis and to produce energy during nutrient depri
87 in lysosomes, contributes to maintenance of proteostasis and to the cellular adaptation to stress.
88 on neuronal activity-mediated regulation of proteostasis and transcellular propagation of protein ag
89 uced protein turnover, increasingly abnormal proteostasis and, ultimately, faster onset of disease sy
90 ineries and networks of protein homeostasis (proteostasis) and stress resistance pathways as critical
91 directed more toward somatic maintenance and proteostasis, and away from cell growth and proliferatio
95 to be especially susceptible to failures in proteostasis, and this is now increasingly recognized as
96 eas failure to maintain protein homeostasis (proteostasis) appears to be a component of aging and a v
97 Imbalances in endoplasmic reticulum (ER) proteostasis are associated with etiologically-diverse d
98 od, abnormal protein aggregation and altered proteostasis are common features of sporadic and familia
100 chondrial dynamics, and protein homeostasis (proteostasis) as fundamental regulators of stem cell fun
102 membrane-anchored AAA+ enzyme that controls proteostasis at the inner membrane and intermembrane spa
103 pathway are unlikely attributed to defective proteostasis because up-regulation of protein synthesis
106 een associated with a progressive decline of proteostasis, but how this process affects proteome comp
107 results suggest Hsp90 and p23 contribute to proteostasis by chaperoning mature factors through energ
108 rotein aggregates for degradation, and reset proteostasis by enveloping and clearing the aggregates.
109 ed the effect of chronic hyperinsulinemia on proteostasis by generating a time-resolved map of insuli
110 o-chlorobenzylidene)amino]guanidines restore proteostasis by interfering with eIF2alpha-P dephosphory
111 the cellular lipid landscape that disrupt ER proteostasis by interfering with the glycan trimming and
115 rt the notion that cytosolic Fes1S maintains proteostasis by supporting the removal of toxic misfolde
116 h diverse cellular activities) that maintain proteostasis by unfolding aberrant and toxic proteins fo
117 mary, we demonstrate that targeting cellular proteostasis can inhibit norovirus replication, identify
119 y regulated; changes in folding homeostasis (proteostasis) can disrupt many cellular processes and ha
120 s innate protective pathway, which maintains proteostasis, can be harnessed effectively to protect ol
121 here a novel response pathway that enhances proteostasis capacity and appears to act in parallel to
124 We consider different strategies to modulate proteostasis capacity, which may help develop urgently n
126 c hyponatremia induces severe alterations in proteostasis characterized by diffuse protein aggregatio
128 by the absence of sperm exhibit hallmarks of proteostasis collapse, including protein aggregation.
129 an illuminate the interplay between cellular proteostasis components and their distinct substrates.
131 stress, including oncogenic transformation, proteostasis components maintain homeostasis and prevent
132 oplasmic reticulum (ER) stress and disrupted proteostasis contribute to the pathogenesis of a variety
133 tal muscle, which is a loss of mitochondrial proteostasis, contributes to tissue dysfunction and nega
135 Our study suggests that manipulation of proteostasis could be an alternative approach to the tre
138 findings support the oncogenic relevance of proteostasis deregulation in hematopoietic cells, and th
139 ects organisms from symptoms associated with proteostasis disorders, suggesting that protein clearanc
140 , may lead to defective protein homeostasis (proteostasis) due to hyperactivation of insulin-sensitiv
145 inflammatory secretory phenotype, defects in proteostasis, epigenetic changes, deregulated nutrient s
146 ext-generation shRNA platform, we found that proteostasis factors, including chaperones and stress-re
153 hus, a lysosomal switch that enhances oocyte proteostasis in anticipation of fertilization may be con
156 workshop on "Malformed Protein Structure and Proteostasis in Lung Diseases" was to identify mechanist
157 highlights a previously overlooked role for proteostasis in maintaining cell survival in the absence
160 omplex interplay between innate immunity and proteostasis in neurodegenerative diseases, an interacti
161 of which are shown to disrupt mitochondrial proteostasis in other contexts-we hypothesized that fail
162 a central role in the loss of mitochondrial proteostasis in skeletal muscle ageing, as well as its b
163 nerves and/or muscle modifies mechanisms of proteostasis in skeletal muscle and plays a key role in
164 nvolved in coordinating ER and extracellular proteostasis in the presence and absence of ER stress.
166 We propose that VCP sustains sarcoplasmic proteostasis, in part, by controlling the integrity of a
168 s that adversely affect protein homeostasis (proteostasis), including extreme temperatures, toxins, a
169 rone, which plays a central role in cellular proteostasis, including quality control during protein r
170 Disturbance of endoplasmic reticulum (ER) proteostasis is a common feature of amyotrophic lateral
171 mental illness as a result of disruptions in proteostasis is an emerging theme in the study of schizo
172 Trans-NIH Geroscience Initiative and loss of proteostasis is associated with aging and age-related ch
174 terminants, the loss of proteostasis - where proteostasis is defined here as the maintenance of the p
183 r chaperone for maintenance of mitochondrial proteostasis, is highly expressed in glioblastoma patien
185 ls evoke an adaptive mechanism to restore ER proteostasis known as the unfolded protein response (UPR
186 olutionarily conserved regulator of cellular proteostasis linked to longevity in nematodes, but its b
189 respond to oxidative stress by up-regulating proteostasis machinery, but the direct activation of mam
195 ppression of genes essential for maintaining proteostasis; many are hub genes - involved in RNA proce
196 arly, interspecific comparisons suggest that proteostasis may be an important lifespan determinant in
198 nd that autophagy is an important endogenous proteostasis mechanism and an attractive target for ther
203 ential in all organisms and regulated by the proteostasis network (PN) and cell stress response pathw
205 n aggregation is routinely suppressed by the proteostasis network (PN), a collection of macromolecula
206 ggregates that challenge the capacity of the proteostasis network (PN), increasing the risk for disea
209 additional inputs/factors in this underlying proteostasis network and demonstrates the utility of zeb
210 artnership between two key components of the proteostasis network and implicate autophagy defects in
211 olerance of the heart presumably through the proteostasis network and reinforces the critical role of
212 in the first experimental paradigm, cellular proteostasis network capacity and its dynamics are refle
213 client-based probes to quantify the cellular proteostasis network capacity in real time is highly des
215 transcriptional program augmenting cytosolic proteostasis network capacity, and in part by time-depen
216 tasis in these organelles is maintained by a proteostasis network containing protein chaperones, pept
218 te to aggregate formation, components of the proteostasis network dictate the fate of protein aggrega
222 tional role of specific components of the ER proteostasis network in the cellular changes associated
226 ret this result to reflect the presence of a proteostasis network that can "sense" protein stability.
227 can result in non-oncogene addiction to the proteostasis network that can be exploited clinically.
228 these data identify ERdj5 as a member of the proteostasis network that regulates rod opsin biogenesis
229 ategies to target-specific components of the proteostasis network using small molecules and gene ther
230 nate up-regulation of proteins in the global proteostasis network, including ribosomal, proteasomal,
232 challenges the cellular protein homeostasis (proteostasis) network capacity of cells by consuming cha
233 contain an extensive protein homeostasis (or proteostasis) network comprising molecular chaperones an
234 ated with an unbalanced protein homeostasis (proteostasis) network, which sensitizes cancer cells to
235 ting cancer subtype-specific dependencies on proteostasis networks to uncover unanticipated cancer vu
236 highlight the multidimensional nature of the proteostasis networks, which allow for coordinated prote
237 identify profound rearrangement in cellular proteostasis occurring very early on after loss of ATM i
240 nslocation selectively impaired glycoprotein proteostasis of influenza as well as HIV and dengue viru
241 cement, represents a new strategy to restore proteostasis of misfolding-prone GABAA receptors and, th
242 n-dependent folding system also controls the proteostasis of other membrane proteins as CFTR and anth
244 rone activities of Ranbp2 cyclophilin toward proteostasis of selective substrates and with novel ther
246 endoplasmic reticulum lumen regulates normal proteostasis of the secretory pathway; they also support
248 cosylation alters the protein homeostasis or proteostasis of wild-type (WT) and R345W F3 in ARPE-19 c
249 ent aspects of chaperone control of neuronal proteostasis on topics ranging from chaperone engineerin
252 e studies allude to the existence of a novel proteostasis pathway that mechanistically links misfolde
253 logy, we explored the role of major cellular proteostasis pathways and mitochondrial proteases in FXN
260 ve proteomics of clpt1 clpt2 plants showed a proteostasis phenotype similar to viable mutants in ClpP
262 We probed the ER retention process using the proteostasis regulator 4-phenylbutyrate (4-PBA), which w
263 ing the mechanisms of action of F508del-CFTR proteostasis regulator drugs through an approach based o
264 ed a rationale for therapeutically targeting proteostasis regulators (e.g., HSP90), cancer-subtype de
265 l and physical interactions between VAPB and proteostasis regulators (ligands), including the unfolde
268 function, it has been assumed that synaptic proteostasis requires the ubiquitin-proteasome system (U
269 Ensuring cellular protein homeostasis, or proteostasis, requires precise control of protein synthe
270 e that SQRD-1 activity in H2S may coordinate proteostasis responses in multiple cellular compartments
271 stressors that disrupt protein homeostasis (proteostasis), resulting in protein misfolding and aggre
272 ies indicated by these recent discoveries in proteostasis science that will advance our molecular und
275 g mHtt structural properties to its neuronal proteostasis should inform new strategies for neuroprote
276 stability and folding and not by markers of proteostasis stress such as protein carbonylation and ag
277 s an enabler, allowing cancer cells to evade proteostasis stress triggered by oncogene activation.
278 13, the depletion of FGF13 elicits increased proteostasis stress, associated with the accumulation of
279 e that, as part of the in vivo extracellular proteostasis system, the plasminogen activation system m
280 ution, and into the potential design of host proteostasis-targeted antiviral therapeutics that are re
282 t mutation (F508del-CFTR) results in altered proteostasis, that is, in the misfolding and intracellul
283 bound to a large set of genes implicated in proteostasis, the acute-phase response, metabolism, and
284 systems of Escherichia coli work together in proteostasis: the recognition, sorting, folding, and dis
285 ts suggest that TRiC contributes to AML1-ETO proteostasis through specific interactions between the o
286 ation also directly influences extracellular proteostasis through the upregulation and secretion of t
287 nse (UPR) indirectly regulates extracellular proteostasis through transcriptional remodeling of endop
289 ort the relevance of enhancing mitochondrial proteostasis to delay amyloid-beta proteotoxic diseases,
290 Therefore, tumors exploit ClpXP-directed proteostasis to maintain mitochondrial bioenergetics, bu
291 nant state, and disrupting the fragile tumor proteostasis to promote amyloidogenesis may be a feasibl
292 clear that the capacity of cells to maintain proteostasis undergoes a decline during aging, rendering
294 such as yeast Cur1 protein, play key role in proteostasis via tight control of partitioning and recyc
297 conserved lifespan determinants, the loss of proteostasis - where proteostasis is defined here as the
298 t these cells suffer from a profound loss in proteostasis, which sensitizes them to the expression of
299 , describes new work in the area of neuronal proteostasis, with a specific focus on the roles and the
300 haperone protein responsible for maintaining proteostasis, yet how its structure translates into func
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。